While overall survival was high in this cohort, patients with the highest (top 20%) CHMP5 expression had worse overall survival (Log-rank test, P = 0.017) compared to T-ALL patients with the lowest (bottom 20%) CHMP5 expression levels (Fig. 5d). This evidence concerns the gene CHMP5 and acute lymphoblastic leukemia.